NRSG 3100 Units 10-11 Questions With Complete Solutions
abciximab (ReoPro) adverse effects Correct Answer major
bleeds in 10% of patients (starts most often at arterial or venous
access site); report unusual bleeding or if bleeding lasts longer
than 15 minutes
abciximab (ReoPro) antidote Correct Answer no antidote; can
give platelets
abciximab (ReoPro) classification Correct Answer antiplatelet
agent
abciximab (ReoPro) treats Correct Answer prvent
thrombolytic event in acute coronary syndrome; decrease
platelet function in 2 hours and lasts up to 10 days
alteplase (Activase) adverse effects Correct Answer bleeding
(catheter access, needle puncture sites or internally), any
abnormal bleeding should be reported
alteplase (Activase) classification Correct Answer
thrombolytic
alteplase (Activase) treats Correct Answer drug of choice for
thrombotic stroke and central line clots; MI; faster onset than
alteplase
aminocaproic acid (Amicar) adverse effects Correct Answer
rapid IV=decreased blood pressure and heart rate,
rhabdomyolysis
, aminocaproic acid (Amicar) classification Correct Answer
hemostatic/antifibrynolytic
aminocaproic acid (Amicar) treats Correct Answer aplastic
anemia, hepatic cirrhosis, post-op cardiac surgery; action
opposite of anticoags; prevents fibrin from disolving
antidote for alteplase (Activase) Correct Answer no antidote
antidote for retaplase (Retavase) Correct Answer no antidote,
patient needs bed rest while on medication to avoid injury
D10W Correct Answer Administer slowly; caustic to veins,
want large vein or central line; 10 grams/100 ml
D10W classification Correct Answer Anti hypoglycemic
D50W Correct Answer 25 grams/50 ml; hypertonic; large
vein; monitor for hyperglycemia
D50W classification Correct Answer Anti hypoglycemic
desmopressin (DDAVP) adverse effects Correct Answer
Water intoxication, anaphylaxis; watch I&Os and daily weights)
desmopressin (DDAVP) classification Correct Answer Anti
diuretic hormone replacement
desmopressin (DDAVP) contraindications Correct Answer
Renal impairment, nephro DI
abciximab (ReoPro) adverse effects Correct Answer major
bleeds in 10% of patients (starts most often at arterial or venous
access site); report unusual bleeding or if bleeding lasts longer
than 15 minutes
abciximab (ReoPro) antidote Correct Answer no antidote; can
give platelets
abciximab (ReoPro) classification Correct Answer antiplatelet
agent
abciximab (ReoPro) treats Correct Answer prvent
thrombolytic event in acute coronary syndrome; decrease
platelet function in 2 hours and lasts up to 10 days
alteplase (Activase) adverse effects Correct Answer bleeding
(catheter access, needle puncture sites or internally), any
abnormal bleeding should be reported
alteplase (Activase) classification Correct Answer
thrombolytic
alteplase (Activase) treats Correct Answer drug of choice for
thrombotic stroke and central line clots; MI; faster onset than
alteplase
aminocaproic acid (Amicar) adverse effects Correct Answer
rapid IV=decreased blood pressure and heart rate,
rhabdomyolysis
, aminocaproic acid (Amicar) classification Correct Answer
hemostatic/antifibrynolytic
aminocaproic acid (Amicar) treats Correct Answer aplastic
anemia, hepatic cirrhosis, post-op cardiac surgery; action
opposite of anticoags; prevents fibrin from disolving
antidote for alteplase (Activase) Correct Answer no antidote
antidote for retaplase (Retavase) Correct Answer no antidote,
patient needs bed rest while on medication to avoid injury
D10W Correct Answer Administer slowly; caustic to veins,
want large vein or central line; 10 grams/100 ml
D10W classification Correct Answer Anti hypoglycemic
D50W Correct Answer 25 grams/50 ml; hypertonic; large
vein; monitor for hyperglycemia
D50W classification Correct Answer Anti hypoglycemic
desmopressin (DDAVP) adverse effects Correct Answer
Water intoxication, anaphylaxis; watch I&Os and daily weights)
desmopressin (DDAVP) classification Correct Answer Anti
diuretic hormone replacement
desmopressin (DDAVP) contraindications Correct Answer
Renal impairment, nephro DI
